BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 16435724)

  • 1. [Ascites, spontaneous bacterial peritonitis and hepatorenal syndrome].
    Gerbes AL; Gülberg V
    Dtsch Med Wochenschr; 2005 Dec; 130 Suppl 5():S237-9. PubMed ID: 16435724
    [No Abstract]   [Full Text] [Related]  

  • 2. EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis.
    European Association for the Study of the Liver
    J Hepatol; 2010 Sep; 53(3):397-417. PubMed ID: 20633946
    [No Abstract]   [Full Text] [Related]  

  • 3. Management of ascites in the patient with portal hypertension with emphasis on spontaneous bacterial peritonitis.
    Navasa M; Rodés J
    Semin Gastrointest Dis; 1997 Oct; 8(4):200-9. PubMed ID: 9360284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The clinical management of abdominal ascites, spontaneous bacterial peritonitis and hepatorenal syndrome: a review of current guidelines and recommendations.
    Pericleous M; Sarnowski A; Moore A; Fijten R; Zaman M
    Eur J Gastroenterol Hepatol; 2016 Mar; 28(3):e10-8. PubMed ID: 26671516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of ascites and spontaneous bacterial peritonitis - part I.
    Bendtsen F; Grønbaek H; Hansen JB; Aagaard NK; Schmidt L; Møller S
    Dan Med J; 2012 Jan; 59(1):C4371. PubMed ID: 22239847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ascites.
    Gordon FD
    Clin Liver Dis; 2012 May; 16(2):285-99. PubMed ID: 22541699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of ascites in patients with end-stage liver disease.
    Saadeh S; Davis GL
    Rev Gastroenterol Disord; 2004; 4(4):175-85. PubMed ID: 15580152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ascites and hepatorenal syndrome: pathogenesis and treatment strategies.
    Ginès P; Arroyo V; Rodés J
    Adv Intern Med; 1998; 43():99-142. PubMed ID: 9506180
    [No Abstract]   [Full Text] [Related]  

  • 9. [Therapy of complications of hepatic cirrhosis].
    Töx U; Goeser T
    Praxis (Bern 1994); 2005 May; 94(18):727-33. PubMed ID: 15938384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. β-blockers and refractory ascites in cirrhosis: the message of a team of true scientists.
    Angeli P
    J Hepatol; 2011 Oct; 55(4):743-4. PubMed ID: 21396970
    [No Abstract]   [Full Text] [Related]  

  • 11. [Physiopathology of refractory ascites and the hepatorenal syndrome].
    Arroyo V
    Nefrologia; 2002; 22 Suppl 5():41-6. PubMed ID: 12107916
    [No Abstract]   [Full Text] [Related]  

  • 12. [Ascites, spontaneous bacterial peritonitis, hepatorenal syndrome: What is common in their diagnosis and treatment?].
    Bakulin IG; Varlamicheva AA
    Ter Arkh; 2015; 87(4):77-83. PubMed ID: 26087639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical management of ascites and its complications.
    Wongcharatrawee S; Garcia-Tsao G
    Clin Liver Dis; 2001 Aug; 5(3):833-50. PubMed ID: 11565143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of ascites in cirrhosis.
    Sandhu BS; Sanyal AJ
    Clin Liver Dis; 2005 Nov; 9(4):715-32, viii. PubMed ID: 16207572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of ascites.
    Buckley SE; Herrera JL
    Compr Ther; 1995 Apr; 21(4):195-9. PubMed ID: 7796576
    [No Abstract]   [Full Text] [Related]  

  • 16. Review article: Management of ascites and associated complications in patients with cirrhosis.
    Kuiper JJ; de Man RA; van Buuren HR
    Aliment Pharmacol Ther; 2007 Dec; 26 Suppl 2():183-93. PubMed ID: 18081661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Minimizing ascites. Complication of cirrhosis signals clinical deterioration.
    Garcia N; Sanyal AJ
    Postgrad Med; 2001 Feb; 109(2):91-6, 101-3. PubMed ID: 11272697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Ascites, hepatorenal syndrome and spontaneous bacterial peritonitis in patients with portal hypertension].
    Kim YS
    Korean J Gastroenterol; 2010 Sep; 56(3):168-85. PubMed ID: 20847607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Influence of circulatory dysfunction on the treatment of ascites and hepatorenal syndrome: vasoconstrictor and diuretic drug treatment].
    Torre A; Terra C; Guevara M; Ginès P
    Gastroenterol Hepatol; 2004 Feb; 27 Suppl 1():8-14. PubMed ID: 15195529
    [No Abstract]   [Full Text] [Related]  

  • 20. Management of cirrhotic ascites.
    Bashyam M; Lepore M; Harbord M
    Br J Hosp Med (Lond); 2015 Feb; 76(2):C28-32. PubMed ID: 25671487
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.